GlassScriptPhysician profile
Blessing L Nollah
NPI 1043454374
$1,256.18
in general payments reported to CMS, 2019-2025
24 companies · $34.79 in 2025
The $34.79 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $968 · 2020: $157 · 2022: $21.76 · 2024: $74.59 · 2025: $34.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $74.59 · Food and Beverage: $34.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $74.59 |
| Food and Beverage | $34.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $277.26 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $151.59 | 2019-2020 | |
| Amgen INC. | $131.52 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $119.30 | 2019 | |
| Eisai INC. | $97.57 | 2019-2022 | |
| Lilly USA, LLC | $74.59 | 2024 | |
| Array Biopharma INC | $46.67 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.31 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $42.35 | 2019 | |
| Abbvie INC. | $34.79 | 2025 | |
| Biom'Up France Sas | $29.09 | 2020 | |
| Genentech USA, INC. | $25.23 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $21.66 | 2019 | |
| Tesaro, INC. | $18.98 | 2019 | |
| Kyowa Kirin, INC. | $18.32 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verastem, INC. | $17.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.03 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $16.76 | 2019 | |
| Genzyme Corporation | $13.79 | 2019 | |
| Seagen INC. | $12.43 | 2019 | |
| Astellas Pharma US INC | $11.49 | 2019 | |
| Jazz Pharmaceuticals INC. | $11.14 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.01 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blessing Nollah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.